<DOC>
	<DOCNO>NCT02216357</DOCNO>
	<brief_summary>The primary objective study determine safety oral ifetroban compare placebo measure &gt; 20 % decrease FEV1 compare baseline follow dose Investigational Medicinal Product ( IMP ) ( Study Day 1 2 ) prior initiation aspirin challenge .</brief_summary>
	<brief_title>Trial Determine Safety Oral Ifetroban Patients With History Aspirin Exacerbated Respiratory Disease</brief_title>
	<detailed_description />
	<mesh_term>Respiration Disorders</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ifetroban</mesh_term>
	<criteria>1 . Adults history physiciandiagnosed stable asthma ( FEV1 least 1.25 liter 60 % good predicted* two previous visit 10 % variation value , increase baseline dose oral glucocorticoid asthma least three month , history hospitalization emergency room visit asthma least prior six month ) . 2 . Have history nasal polyposis . 3 . Have history least one clinical reaction oral aspirin nonselective cyclooxygenase ( COX ) inhibitor feature low ( cough , chest tightness , wheeze , dyspnea ) and/or upper ( rhinorrhea , sneeze , nasal obstruction , conjunctival itch discharge ) airway involvement . 4 . Currently receive montelukast ( least 10 mg per day , oral ) Zafirlukast ( least 20 mg twice per day , oral ) , least 1 week therapy prior first dose IMP . 1 . Be less 18 year age great equal 65 year age . 2 . Be pregnant , nursing , plan become pregnant . 3 . Be current tobacco smoker ( defined daily tobacco smoker six month precede study one instance tobacco smoking last three month ) . 4 . Use beta blocker last week . 5 . Use antihistamine 48 hour prior first dose IMP . 6 . Use nasal decongestant 48 hour prior first dose IMP . 7 . Use aspirin nonsteroidal inflammatory drug ( NSAID ) last two week . 8 . Use zileuton last two week . 9 . Have require one dose â‰¥ 40 mg prednisone equivalent last two week . 10 . Have history systemic lifethreatening respiratory reaction aspirin require intubation administration epinephrine . 11 . Have history peptic ulcer disease , gastrointestinal bleed , current severe gastroesophageal reflux disease ( GERD ) , define patient currently require two total dos medication per day treat persistent symptom : either two dos single medication type ( antacid , proton pump inhibitor , H2 receptor antagonist ) , 2 type medication per day treat symptom . 12 . Have history tolerate COX1 block drug history respiratory reaction similar drug . 13 . Have history cardiovascular disease include myocardial infarction , heart failure , atrial ventricular rhythm disturbance , angina , previous abnormal electrocardiogram . 14 . Have history bleeding diathesis use anticoagulant antiplatelet drug last two week . 15 . Have history allergy hypersensitivity ifetroban . 16 . Have take investigational drug within 30 day IMP administration . 17 . Inability understand requirement study , inability understand speak English abide study restriction return require treatment assessment . 18 . Be otherwise unsuitable study , opinion investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Samster 's triad</keyword>
	<keyword>Acetylsalicylic acid triad</keyword>
	<keyword>Widal 's triad</keyword>
	<keyword>Francis ' triad</keyword>
	<keyword>Aspirin triad</keyword>
	<keyword>Aspirin-induced asthma rhinitis ( AIAR )</keyword>
</DOC>